Buyers Say Teva Had Multipart Scheme To Delay Inhaler Rivals

By Matthew Perlman · July 10, 2024, 6:35 PM EDT

Employee benefit funds accusing Teva of orchestrating a decadelong scheme to delay generic competition for its QVAR asthma inhalers told a Massachusetts federal court the drugmaker is trying to end the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login